Back
Brainstorm Cell Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
BCLI
Brainstorm Cell Therapeutics, Inc.
Last Price:
$0.86
Seasonality Move:
-2.9%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and BCLI is experiencing slight selling pressure.
Brainstorm Cell Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.9 | Sell |
| 20-day SMA: | 0.84 | Buy |
| 50-day SMA: | 0.7 | Buy |
| 200-day SMA: | 0.72 | Buy |
| 8-day EMA: | 0.89 | Sell |
| 20-day EMA: | 0.84 | Buy |
| 50-day EMA: | 0.75 | Buy |
| 200-day EMA: | 1.2 | Sell |
Brainstorm Cell Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 55.64 | Buy |
| Chaikin Money Flow: | -7689 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.72 - 0.9) | Buy |
| Bollinger Bands (100): | (0.54 - 0.76) | Buy |
Brainstorm Cell Therapeutics, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Brainstorm Cell Therapeutics, Inc. Stock
Is Brainstorm Cell Therapeutics, Inc. Stock a Buy?
-
Brainstorm Cell Therapeutics, Inc. share price is 0.86 while BCLI 8-day simple moving average is 0.90, which is a Sell signal.
-
The stock price of BCLI is 0.86 while Brainstorm Cell Therapeutics, Inc. 20-day SMA is 0.84, which makes it a Buy.
-
Brainstorm Cell Therapeutics, Inc. 50-day simple moving average is 0.70 while BCLI share price is 0.86, making it a Buy technically.
-
BCLI stock price is 0.86 and Brainstorm Cell Therapeutics, Inc. 200-day simple moving average is 0.72, creating a Buy signal.
BCLI Technical Analysis vs Fundamental Analysis
Sell
37
Brainstorm Cell Therapeutics, Inc. (BCLI)
is a Sell
Is Brainstorm Cell Therapeutics, Inc. a Buy or a Sell?
-
Brainstorm Cell Therapeutics, Inc. stock is rated a SellThe current Brainstorm Cell Therapeutics, Inc. [BCLI] share price is $0.86. The Score for BCLI is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Brainstorm Cell Therapeutics, Inc. Stock Info
Market Cap:
8.6M
Price in USD:
0.86
Share Volume:
23.2K
Brainstorm Cell Therapeutics, Inc. 52-Week Range
52-Week High:
3.99
52-Week Low:
0.46
Sell
37
Brainstorm Cell Therapeutics, Inc. (BCLI)
is a Sell
Brainstorm Cell Therapeutics, Inc. Share Price Forecast
-
What is the Brainstorm Cell Therapeutics, Inc. stock price today?The Brainstorm Cell Therapeutics, Inc. stock price is 0.86 USD today.
-
Will BCLI stock go up or go down?Brainstorm Cell Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Brainstorm Cell Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Brainstorm Cell Therapeutics, Inc. is overvalued.
Is Brainstorm Cell Therapeutics, Inc. Stock a Buy?
-
Brainstorm Cell Therapeutics, Inc. share price is 0.86 while BCLI 8-day exponential moving average is 0.89, which is a Sell signal.
-
The stock price of BCLI is 0.86 while Brainstorm Cell Therapeutics, Inc. 20-day EMA is 0.84, which makes it a Buy.
-
Brainstorm Cell Therapeutics, Inc. 50-day exponential moving average is 0.75 while BCLI share price is 0.86, making it a Buy technically.
-
BCLI stock price is 0.86 and Brainstorm Cell Therapeutics, Inc. 200-day simple moving average is 1.20, creating a Sell signal.
Fundamental Analysis of Brainstorm Cell Therapeutics, Inc.
Is Brainstorm Cell Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.54 per share, and an increase next year of $0.21 per share.
Technical Analysis of Brainstorm Cell Therapeutics, Inc.
Should I short Brainstorm Cell Therapeutics, Inc. stock?
-
BCLI Moving Average Covergence Divergence (MACD) indicator is 0.06, suggesting Brainstorm Cell Therapeutics, Inc. is a Buy
-
Brainstorm Cell Therapeutics, Inc. Relative Strength Index (RSI) is 55.64, which suggest Brainstorm Cell Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Brainstorm Cell Therapeutics, Inc. is (0.72 - 0.9), which suggest Brainstorm Cell Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Brainstorm Cell Therapeutics, Inc. is (0.54 - 0.76), which suggest Brainstorm Cell Therapeutics, Inc. is a Buy
* Brainstorm Cell Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.